To further evaluate the role of lactoferrin in COVID-19, we designed a randomized, double-blind, placebo-controlled, multicenter clinical trial to investigate the efficacy of a daily oral dose of bovine lactoferrin in combination with the standard of care in improving clinical recovery and reducing adverse outcomes in hospitalized patients affected by moderate-to-severe COVID-19. Here, LTF is linked to COVID-19.